Leading-edge clinical solutions for neurological and physical recovery.
Stroke remains a leading cause of long-term disability worldwide, affecting over 15 million people annually. As global populations age, the demand for sophisticated stroke rehabilitation aids has shifted from simple mechanical supports to intelligent robotic systems. Today, the industry is valued at billions of dollars, with North America, Europe, and the Asia-Pacific region leading the clinical adoption of neuro-rehab technologies.
Hospitals and specialized clinics are no longer looking for standalone equipment; they require integrated digital ecosystems that can track patient progress in real-time. This is where high-quality suppliers and factories play a critical role, bridging the gap between clinical research and practical bedside application.
Modern rehabilitation is defined by neuroplasticity-driven robotics. Machines now use AI to detect a patient's intention to move, providing just enough assistance to complete the task, thereby "rewiring" the brain more effectively than traditional passive therapy.
Precision diagnostics through 3D Gait Analysis and Plantar Pressure Evaluation allow therapists to visualize microscopic deviations in walking patterns, leading to highly personalized treatment protocols.
Technologies like Transcranial Electric Stimulation (TES) and Magnetic Stimulation are becoming standard in factories and suppliers' portfolios, offering non-invasive ways to stimulate cortical excitability.
Years Experience
China Hospital Coverage
OEM Global Clients
Patents & Copyrights
With over 30 years of medical legacy and 15 years dedicated exclusively to rehabilitation R&D, Xinkang is a pillar of authority in the Chinese medical device industry. We integrate production, sales, and clinical research into a closed loop, ensuring every product is backed by empirical data and professional expertise.
We are a domestic leader in physical factor treatment products including:
R&D Achievement Overview:
1 Invention Patent | 3 Design Patents | 7 Utility Model Patents | 13 Software Copyrights | 10 Registered Trademarks
Located in the heart of China's high-tech manufacturing hub, our 10,000+ SQM factory houses 30+ standard OEM production lines. This allows us to scale production while maintaining the rigorous quality required for medical-grade certifications.
We understand that rehabilitation protocols differ between Germany, the USA, and Japan. Our R&D team offers personalized customized services for equipment, sales management, and brand building to suit local market regulations.
By leveraging China's complete industrial supply chain, we offer high-quality stroke rehabilitation aids at a cost-performance ratio that is unbeatable by European or American counterparts, without sacrificing clinical efficacy.
In China, Xinkang products cover more than 75% of tertiary medical units. This high penetration rate is due to our systems' ability to handle high-volume patient turnover while providing the diagnostic depth required by top-tier neurologists.
A growing global trend is "Early Discharge, Continued Rehab." Our portable Transcranial Electric Stimulators and Wearable Walking Assist Robots are designed for this transition, allowing patients to continue their stroke recovery in the comfort of their homes while remaining connected to their clinical data via our software copyrights.
Our quality standards are referenced against international peers. Every process in the product manufacturing cycle is controlled through a standardized management system.
MedTrack
